Rosacea does not have a single cause. It develops from a collision of genetic susceptibility, an overactive innate immune system, microscopic skin mites, neurovascular hypersensitivity, and environmental triggers that vary from person to person. Twin studies estimate that genetics accounts for roughly 46% of the variation in rosacea severity, which means the other half comes from everything else your skin encounters and how it responds. Understanding which of these factors matters most for you can change the way you manage the condition and, in some cases, point toward treatments you might not have considered.
The Genetic Foundation
Rosacea runs in families more consistently than most people realize. A study tracking rosacea across extended family trees found that about half of patients had at least one affected relative, and when researchers looked beyond parents and siblings to the broader family, the proportion of relatives with rosacea climbed to nearly 70%.1PubMed Central. Intrafamilial Transmission of Rosacea Spanning Six Generations: A Retrospective Observational Study A large twin study put a finer point on this by comparing identical twins (who share all their DNA) with fraternal twins (who share about half). Identical twins’ rosacea severity scores tracked much more closely with each other than fraternal twins’ scores did, and the researchers estimated genetics contributes about 46% of the overall variation in the condition.2PubMed. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins
Recent whole-genome sequencing work has started identifying specific genes involved. A 2023 study sequenced the genomes of members of large rosacea-affected families and found rare damaging variants in genes called LRRC4, SH3PXD2A, and SLC26A8. When researchers introduced these mutations into human nerve cells in the lab, the cells pumped out abnormally high levels of vasoactive neuropeptides, the signaling molecules that dilate blood vessels and trigger inflammation. Mice carrying one of these mutations developed rosacea-like skin inflammation driven by excessive release of a neuropeptide called VIP from peripheral nerves.3Nature Communications. Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea These findings connect genetics directly to the flushing and redness that define the disease: certain inherited mutations prime the nervous system to overreact, flooding the skin with signals that widen blood vessels and attract inflammatory cells.
Demodex Mites and the Bacteria They Carry
Everyone has Demodex folliculorum mites living in their facial hair follicles. They are a normal part of your skin’s ecosystem. But people with rosacea tend to harbor far more of them. Research consistently shows that mite density on rosacea-affected skin is higher than on healthy skin, with the highest counts found in the papulopustular subtype (the kind with bumps and pus-filled lesions).4PubMed. Potential role of Demodex mites and bacteria in the induction of rosacea Even in the earlier, redness-dominated stage of rosacea, mite density tends to sit between the low levels found on healthy skin and the much higher levels seen in full-blown papulopustular disease, suggesting that mite proliferation may be part of a gradual escalation.5PubMed Central. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?
The mites themselves are probably not the main irritant. What matters more is what lives inside them. A bacterium called Bacillus oleronius has been isolated from Demodex mites, and it is not a normal resident of human skin. Antigens from this bacterium triggered an inflammatory immune response in about 73% of rosacea patients tested, compared with only 29% of healthy controls.6PubMed. Mite-related bacterial antigens stimulate inflammatory cells in rosacea This explains a frustrating clinical phenomenon: when treatments kill Demodex mites, some patients experience a temporary flare of redness and bumps before they improve. The dying mites release their bacterial cargo, flooding the skin with inflammatory antigens before the immune system can clear them.7PubMed Central. Efficacy of Treatments in Reducing Inflammatory Lesion Count in Rosacea: A Systematic Review If you have started a mite-targeting treatment like ivermectin and noticed things getting worse before they got better, this is likely the reason.
An Immune System That Overreacts
Even without mites or bacteria, the skin of people with rosacea behaves differently at the molecular level. A key discovery was that rosacea skin produces abnormally high levels of cathelicidin, a natural antimicrobial peptide. Cathelicidin is part of your innate immune defense, your body’s first-responder system against infection. But in rosacea, the peptide gets processed into unusual forms that are especially good at triggering inflammation and blood vessel dilation.8PubMed. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
The reason for this abnormal processing traces back to an enzyme called kallikrein 5 (KLK5), a protease whose activity is dramatically elevated across the entire outer layer of rosacea skin. KLK5 chops up cathelicidin precursors into the inflammatory peptide fragments that cause the redness and swelling characteristic of the disease. When researchers injected these specific cathelicidin fragments into mouse skin, the animals developed rosacea-like inflammation, confirming that the peptides themselves are sufficient to drive the disease process.9Journal of Investigative Dermatology Symposium Proceedings. Rosacea as a Disease of Cathelicidins and Skin Innate Immunity
Layered on top of this innate immune problem is an adaptive immune response. Skin biopsies from rosacea patients across all subtypes show infiltration by immune cells polarized toward what immunologists call the Th1 and Th17 pathways. These pathways drive chronic inflammation and are also implicated in conditions like psoriasis and inflammatory bowel disease. The extent of this T-cell involvement has been called an underestimated hallmark of the disease.10PubMed. Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways
Why Your Face Flushes So Easily
One of the most annoying aspects of rosacea is how predictably certain triggers set off flushing: a hot drink, spicy food, cold wind, a glass of wine, emotional stress. This happens because the sensory nerves in rosacea-affected skin are hypersensitive. Receptors called TRPV1 and TRPA1, which sit on the endings of sensory neurons and on skin cells themselves, respond to a remarkably wide range of stimuli including hot and cold temperatures, spicy compounds, and reactive oxygen species. In rosacea, these receptors appear to be primed for overactivation, meaning stimuli that would produce a barely noticeable flush in someone else can trigger intense redness and a burning sensation in you.11PubMed. Neurovascular aspects of skin neurogenic inflammation
Research has also identified abnormalities in amino acid metabolism that feed into this neurovascular overreactivity. Certain amino acids found at elevated levels in rosacea skin stimulate peripheral neurons and skin cells to produce vasodilation-related neuropeptides and nitric oxide, a potent blood-vessel-widening molecule.12PubMed Central. Aberrant amino acid metabolism promotes neurovascular reactivity in rosacea So the flushing is not merely cosmetic or “all in your head.” It reflects a measurable difference in the chemistry of your skin and the nerves supplying it.
A Skin Barrier That Leaks
Healthy skin acts as a tight seal, holding moisture in and keeping irritants out. In rosacea, that barrier is compromised. Rosacea skin shows severe dryness, elevated pH, decreased hydration, and increased transepidermal water loss, which is a direct measure of how much moisture is escaping through the skin’s surface.13PubMed. Rosacea Is Characterized by a Profoundly Diminished Skin Barrier Comparative studies show that this barrier damage is significantly worse in papulopustular rosacea than even in acne, despite the two conditions sometimes looking similar on the surface.14PubMed Central. Clinical characteristics and epidermal barrier function of papulopustular rosacea: A comparison study with acne vulgaris
A leaky skin barrier creates a vicious cycle. When more irritants penetrate the skin and more moisture escapes, the immune system ramps up its inflammatory response, which further damages the barrier. This is one reason why harsh skincare products and aggressive exfoliation can make rosacea dramatically worse. Protecting and rebuilding the barrier with gentle, non-irritating moisturizers is a genuine therapeutic step, not just a cosmetic preference.
The Gut Connection
A growing body of evidence links rosacea to what is happening inside the digestive tract. A condition called small intestinal bacterial overgrowth (SIBO), where bacteria proliferate abnormally in the small intestine, has been found in almost half of rosacea patients studied, at rates significantly higher than in healthy controls. The association is strongest with the papulopustular subtype. In one study, patients who received a short course of the antibiotic rifaximin to eradicate SIBO saw nearly complete resolution of their skin symptoms, and the improvement held for over nine months without any other skin treatment. Patients who received placebo saw their skin stay the same or worsen until they were given SIBO eradication treatment afterward.15PubMed Central. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut–Skin Axis of Rosacea
This does not mean that every rosacea patient has a gut problem, or that treating the gut will resolve every case. But if you have rosacea alongside persistent bloating, irregular digestion, or other gut symptoms, it may be worth discussing SIBO testing with your doctor. The connection makes biological sense: the same Th1/Th17 immune pathways active in rosacea skin are also involved in intestinal inflammation, and systemic immune activation from the gut can amplify skin disease.
Hormonal Influences
Rosacea is more commonly diagnosed in women than men, and many women report flares around their menstrual cycle, during pregnancy, or at menopause. Recent research is starting to explain why. An analysis of UK Biobank data found that oral contraceptive use was associated with a roughly 20% increase in rosacea risk, and hormone-replacement therapy with about a 31% increase.16PubMed. 17β-Estradiol promotes LL37-induced rosacea-like skin inflammation via G protein-coupled estrogen receptor 30 In mouse experiments, removing the ovaries (and thus estrogen production) reduced rosacea-like skin inflammation, while adding estrogen back made it worse. The mechanism involves a specific estrogen receptor called GPR30 that was overexpressed in rosacea lesions. This work is still early, but it begins to explain the well-known sex difference in rosacea prevalence and why hormonal transitions can trigger flares.
Stress and the Brain-Skin Loop
Anyone who has experienced a rosacea flare during a stressful week already knows there is a connection between emotional state and skin symptoms. The biology behind this is becoming clearer. Rosacea and anxiety or depression share overlapping pathways, including the same TRP channel family involved in flushing, the body’s stress-hormone axis, and the Th1/Th17 immune polarization seen in rosacea skin.17PubMed Central. New Insights into the Mutual Promotion of Rosacea, Anxiety, and Depression from Neuroendocrine Immune Aspects The relationship appears to run in both directions: stress worsens rosacea, and visible rosacea worsens stress and anxiety, creating a feedback loop. This is relevant practically because it means stress management is not a feel-good add-on to rosacea treatment but a genuinely therapeutic component. Techniques that lower sympathetic nervous system activation, whether meditation, exercise, or cognitive behavioral therapy, can reduce the signaling that feeds skin inflammation.
Metabolic Risk Factors
Rosacea has been linked to metabolic disturbances that most people would not associate with a skin condition. Compared with controls, rosacea patients in one study had significantly higher rates of insulin resistance, along with elevated fasting blood glucose, total cholesterol, LDL cholesterol, triglycerides, and blood pressure. C-reactive protein, a marker of systemic inflammation, was also elevated.18PubMed. The relationship between rosacea and insulin resistance and metabolic syndrome This does not mean rosacea causes heart disease or vice versa, but it does suggest that the chronic low-grade inflammation driving rosacea is not confined to the face. If you have rosacea, it may be worth keeping an eye on cardiovascular risk markers at your routine checkups, especially if you have other risk factors.
When Rosacea Affects the Eyes
Rosacea is not exclusively a skin disease. Ocular rosacea, which involves chronic inflammation of the eyelids and the surface of the eye, is a recognized manifestation that can sometimes appear before any skin symptoms develop at all.19PubMed. Ocular manifestations of rosacea: A clinical review The most common features are red, irritated eyelid margins and dysfunction of the meibomian glands, the tiny oil-producing glands that line the eyelids and keep tears from evaporating too quickly. Imaging studies show that rosacea patients have significant loss of meibomian gland tissue, with the degree of gland dropout correlating with the severity of eyelid abnormalities.20PubMed. Morphological and Functional Evaluation of Meibomian Gland Dysfunction in Rosacea Patients
The practical takeaway: if you have rosacea and experience persistent dry eyes, a gritty or burning sensation, or frequently inflamed eyelids, mention it to both your dermatologist and an ophthalmologist. Ocular rosacea responds to treatment but often goes unrecognized because patients and doctors focus on the skin. Meibomian gland dysfunction linked to rosacea has also been associated with abnormal blood lipid profiles, adding another reason to take eye symptoms seriously rather than dismissing them as simple dryness.21PubMed Central. Rosacea Meibomian Gland Dysfunction Posterior Blepharitis May Be a Marker for Earlier Associated Dyslipidaemia and Inflammation Detection and Treatment with Statins
Rosacea in Darker Skin Tones
Rosacea has long been stereotyped as a condition of fair-skinned people of Northern European descent, but it occurs across all skin tones and ethnicities. The perception of rarity in people with darker skin is largely an artifact of how the disease presents and gets recognized. The hallmark facial redness that makes rosacea obvious on pale skin is much harder to see on darker skin. Instead, the bumps and pustules tend to dominate the clinical picture, and post-inflammatory hyperpigmentation can further mask underlying redness.22PubMed Central. Dermatology: how to manage rosacea in skin of colour As a result, people with skin of color are frequently misdiagnosed with acne or other conditions, and rosacea may already be well-established by the time it is correctly identified.23PubMed. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience
Studies in populations with darker skin phototypes have found some notable differences in triggers and presentation. In Saudi women, sun exposure aggravated the disease in 72% of patients, and pruritus (itching) was the most prominent symptom, rather than the burning and stinging more commonly reported by lighter-skinned patients. Papulopustular rosacea was the leading subtype in Tunisian patients at about 69% of cases. Extrafacial involvement, meaning rosacea-like changes appearing on the ears, neck, or scalp, was also more common.24PubMed. Rosacea in skin of color: A comprehensive review If you have darker skin and persistent facial bumps that have not responded to typical acne treatments, rosacea is worth considering.
Rhinophyma and the Question of Progression
One of the more feared outcomes of rosacea is rhinophyma, the gradual thickening and bulbous enlargement of the nose that becomes a permanent structural change. The process behind rhinophyma illustrates how the various causes of rosacea can compound each other. Chronic inflammation leads to permanent swelling of the skin, which creates an environment that favors even more Demodex colonization. The mites in turn drive further inflammation through the activation of growth factors and immune cells, producing progressive scarring and enlargement of the sebaceous glands.25PubMed Central. Management of rhinophyma Rhinophyma is far more common in men than women, for reasons that are not fully understood, and its development is not inevitable. Most rosacea patients never progress to this stage, particularly if they manage triggers and treat flares early.
An Evolutionary Theory
One intriguing hypothesis reframes rosacea not as a pure malfunction but as the side effect of an ancient survival advantage. The theory focuses on cathelicidin, the same antimicrobial peptide that is overproduced in rosacea skin. In Northern European populations, winter sunlight levels are too low for the skin to produce adequate cathelicidin through the normal vitamin D pathway. The hypothesis proposes that Celtic and Nordic populations may have evolved an alternative, vitamin-D-independent pathway for producing cathelicidin, which helped them survive deadly bacterial skin infections like tuberculosis of the skin during long, dark winters. The chronic redness and inflammation of rosacea might be the trade-off, the collateral damage of a defense system that runs too hot.26Acta Dermato-Venereologica. Rosacea: The Blessing of the Celts – An Approach to Pathogenesis Through Translational Research The idea remains speculative, but it offers a compelling explanation for why rosacea is so prevalent in people of Northern European descent and why its underlying immune mechanism seems to be hardwired rather than acquired.